Literature DB >> 6932933

Rational planning of brain tumour therapy based on laboratory investigations: comparison of single- and multiple-dose BCNU schedules.

M L Rosenblum, D A Dougherty, C B Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932933      PMCID: PMC2149264     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


× No keyword cloud information.
  9 in total

1.  An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions.

Authors:  J E Thomson; A M Rauth
Journal:  Radiat Res       Date:  1974-05       Impact factor: 2.841

2.  Pharmacological and biochemical effects of some reserpine derivatives.

Authors:  S GARATTINI; L LAMESTA; A MORTARI; L VALZELLI
Journal:  J Pharm Pharmacol       Date:  1961-09       Impact factor: 3.765

3.  Response of mouse skin and the C3HBA mammary carcinoma of the C3H mouse to x-rays and cyclotron neutrons: effect of mixed neutron-photon fractionation schemes.

Authors:  J S Nelson; R E Carpenter; R G Parker
Journal:  Eur J Cancer       Date:  1975-12       Impact factor: 9.162

4.  Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase.

Authors:  S Lehnert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-06       Impact factor: 7.038

5.  Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by phenothiazine and reserpine derivatives.

Authors:  F Honda; H Imamura
Journal:  Biochim Biophys Acta       Date:  1968-06-18

6.  Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.

Authors:  S C Rockwell; R F Kallman; L F Fajardo
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

7.  Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors.

Authors:  R F Kallman; G Silini; L M Van Putten
Journal:  J Natl Cancer Inst       Date:  1967-09       Impact factor: 13.506

8.  In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy.

Authors:  M L Rosenblum; K D Knebel; D A Vasquez; C B Wilson
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

9.  Brain-tumor therapy. Quantitative analysis using a model system.

Authors:  M K Rosenblum; K D Knebel; D A Vasquez; C B Wilson
Journal:  J Neurosurg       Date:  1977-02       Impact factor: 5.115

  9 in total
  1 in total

1.  BCNU-induced gR2 defect mediates S-glutathionylation of Complex I and respiratory uncoupling in myocardium.

Authors:  Patrick T Kang; Chwen-Lih Chen; Pei Ren; Giacinta Guarini; Yeong-Renn Chen
Journal:  Biochem Pharmacol       Date:  2014-04-01       Impact factor: 5.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.